Tue, April 13, 2021

Andrew Berens Maintained (ZNTL) at Buy with Increased Target to $64 on, Apr 13th, 2021

Andrew Berens of SVB Leerink, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Buy with Increased Target from $60 to $64 on, Apr 13th, 2021.

Andrew has made no other calls on ZNTL in the last 4 months.



There are 3 other peers that have a rating on ZNTL. Out of the 3 peers that are also analyzing ZNTL, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Andrew


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $65 on, Friday, March 26th, 2021
  • Robert Driscoll of "Wedbush" Initiated at Buy and Held Target at $65 on, Wednesday, January 20th, 2021
  • John Morrison of "Morgan Stanley" Maintained at Buy with Increased Target to $75 on, Wednesday, December 16th, 2020